AngioDynamics | ANGO - Operating Profit

Stock Price
10.81
Daily Change
-0.18 -1.64%
Monthly
2.37%
Yearly
14.88%
Q1 Forecast
11.09

AngioDynamics reported $-9.97M in Operating Profit for its fiscal quarter ending in February of 2025.





Operating Profit Change Date
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -9.97M 1.12M Feb/2025
Artivion USD 4.39M 2.12M Sep/2024
AtriCure USD 2.49M 2.28M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
ICU Medical USD 26.09M 770K Dec/2025
Inogen USD -7.79M 728K Sep/2024
J&J USD 5.59B 1.81B Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 54.2M 11.58M Dec/2025
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Orthofix International USD -84.62M 65.72M Dec/2024
Smiths GBP 242M 21M Dec/2025
Surmodics USD -5.64M 276K Sep/2024
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 445.24M Dec/2025
Terumo JPY 43.88B 1.21B Dec/2025
Trinity Biotech USD -509K 6.27M Sep/2025